Timing of peptide receptor radiotargeted therapy in relation to cardiac valve surgery for carcinoid heart disease in patients with neuroendocrine metastases and cardiac syndrome. A single-centre study from a centre of excellence-Reference-Cited by-同舟云学术

Timing of peptide receptor radiotargeted therapy in relation to cardiac valve surgery for carcinoid heart disease in patients with neuroendocrine metastases and cardiac syndrome. A single-centre study from a centre of excellence

Published:2020-06 Issue:6 Volume:41 Page:575-581
ISSN:0143-3636
Container-title:Nuclear Medicine Communications
language:en
Short-container-title:Nuclear Medicine Communications

Author:

Davis Laura May,Nicou N,Martin Wendy,Corcoran Ben,Mulholland Nicola,Srirajaskanthan R,Ramage J,Wendler O,Vivian G

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Radiology, Nuclear Medicine and imaging,General Medicine

Reference13 articles.

1. Outcomes, risks and complications of cardiac surgery for carcinoid heart disease

2. Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States

3. Carcinoid heart disease: presentation, diagnosis, and management

4. Outcome of cardiac surgery for carcinoid heart disease

5. Optimized Outcomes Using a Standardized Approach for the Treatment of Patients with Carcinoid Heart Disease

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Improving outcomes in carcinoid heart disease – learning from a single centre;Nuclear Medicine Communications;2023-09-04

2. Carcinoid Heart Disease – A 2022 Retrospective;Romanian Journal of Military Medicine;2023-05-01

3. Carcinoid syndrome: a review;Revista Portuguesa de Endocrinologia, Diabetes e Metabolismo;2023

4. Carcinoid Heart Disease: a Review;Current Oncology Reports;2021-03-16

5. Update in carcinoid heart disease - the heart of the matter;Reviews in Endocrine and Metabolic Disorders;2021-01-14